News & Events


News & Events

Latest News

13 November 2017Immunocore Presents Single Agent IMCgp100 data in Metastatic Uveal Melanoma Showing Durability, Doubling in One-Year Overall Survival Rate

31 October 2017Immunocore to Present New Overall Survival Data in Metastatic Uveal Melanoma at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting

04 October 2017Immunocore Appoints Andrew Hotchkiss as Chief Commercial Officer

18 September 2017Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases

07 July 2017Immunocore and MEPC announce significant laboratory expansion at Milton Park in Oxfordshire, UK

03 July 2017Immunocore Announces Third Oncology Target Selected in Discovery Collaboration with GlaxoSmithKline

05 June 2017Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting

01 June 2017Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting

12 May 2017Abbas Hussain Joins the Board of Immunocore as Non-Executive Director

08 May 2017Immunocore identifies second novel ImmTAC® in the GSK collaboration

News alerts

Sign-up to receive news email alerts

Email address

News archive